B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute/NIH (R01CA213131, P50CA107399, P30CA033572)
  • STOP-CANCER Foundation

This publication has 55 references indexed in Scilit: